Novavax annual gross margin
2020
2021
2022
2023
2024
2025
Novavax's gross margin was 93.50% for fiscal 2025.
View full Novavax company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 93.50% | +23.22 pp |
| 2024 | 2024-12-31 | 70.28% | +5.23 pp |
| 2023 | 2023-12-31 | 65.05% | +10.60 pp |
| 2022 | 2022-12-31 | 54.46% | −45.54 pp |
| 2021 | 2021-12-31 | 100.00% | 0.00 pp |
| 2020 | 2020-12-31 | 100.00% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 74.87% | −18.72 pp |
| Q1 2026 | 2026-03-31 | 78.00% | −19.88 pp |
| Q4 2025 | 2025-12-31 | 84.98% | +26.50 pp |
| Q3 2025 | 2025-09-30 | 69.49% | +41.21 pp |
| Q2 2025 | 2025-06-30 | 93.59% | +4.72 pp |
| Q1 2025 | 2025-03-31 | 97.88% | +60.97 pp |
| Q4 2024 | 2024-12-31 | 58.48% | +11.67 pp |
| Q3 2024 | 2024-09-30 | 28.27% | −18.82 pp |
| Q2 2024 | 2024-06-30 | 88.87% | +2.01 pp |
| Q1 2024 | 2024-03-31 | 36.91% | −20.98 pp |
| Q4 2023 | 2023-12-31 | 46.81% | −2.34 pp |
| Q3 2023 | 2023-09-30 | 47.09% | +6.26 pp |
| Q2 2023 | 2023-06-30 | 86.86% | +132.66 pp |
| Q1 2023 | 2023-03-31 | 57.89% | −39.95 pp |
| Q4 2022 | 2022-12-31 | 49.14% | −50.86 pp |
| Q3 2022 | 2022-09-30 | 40.84% | −59.16 pp |
| Q2 2022 | 2022-06-30 | −45.80% | −145.80 pp |
| Q1 2022 | 2022-03-31 | 97.84% | −2.16 pp |
| Q4 2021 | 2021-12-31 | 100.00% | — |
| Q3 2021 | 2021-09-30 | 100.00% | — |
| Q2 2021 | 2021-06-30 | 100.00% | — |
| Q1 2021 | 2021-03-31 | 100.00% | — |
Over the last five fiscal years, Novavax's gross margin decreased from 100.00% to 93.50%, a change of −6.50 percentage points. The latest reported quarter, Q2 2026, shows 74.87%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Novavax source filings ↗